BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

MoonLake Immunotherapeutics (NASDAQ:MLTX)

1 post

Biotech NewsMoonLake (MLTX)’s Sonelokimab Crushes Phase 3 Goals With 35% Response Rate in HS

  • BioTech Health X
  • September 29, 2025
MoonLake Immunotherapeutics (NASDAQ:MLTX) is a clinical-stage biopharmaceutical company dedicated to developing transformative therapies for inflammatory diseases with high…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • 4D Molecular Therapeutics Insider Sells $19,256 as FDMT Surges 27% in a Week
  • Aurora Cannabis (ACB) Poised for Rebound With $309M Market Cap
  • Aurinia Pharmaceuticals (AUPH) Hits $13.45 52-Week High After 80% Surge
  • Applied DNA (APDN) Lands $58M to Fuel Binance Token Bet
  • MoonLake (MLTX)’s Sonelokimab Crushes Phase 3 Goals With 35% Response Rate in HS
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • September 30, 2025
    4D Molecular Therapeutics Insider Sells $19,256 as FDMT Surges 27% in a Week
    • September 30, 2025
    Aurora Cannabis (ACB) Poised for Rebound With $309M Market Cap
    • September 30, 2025
    Aurinia Pharmaceuticals (AUPH) Hits $13.45 52-Week High After 80% Surge
    • September 30, 2025
    Applied DNA (APDN) Lands $58M to Fuel Binance Token Bet
    • September 29, 2025
    MoonLake (MLTX)’s Sonelokimab Crushes Phase 3 Goals With 35% Response Rate in HS
Recent Posts
  • Humana (HUM) Ordered to Pay $32 Million in Whistleblower Case
    • September 29, 2025
  • Johnson & Johnson (JNJ) is Up 22% in 2025
    • September 29, 2025
  • Novo Nordisk (NVO) Surges as Ozempic and Wegovy Drive $48.5B in 2025 Sales
    • September 29, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (1)
  • Biotech News (427)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top